Literature DB >> 23433578

Erythrocyte membrane trans-fatty acid index is positively associated with a 10-year CHD risk probability.

Xiao-Ru Liu1, Ze-Yuan Deng, Jiang-Ning Hu, Ya-Wei Fan, Rong Liu, Jing Li, Jing-Tian Peng, Hai Su, Qiang Peng, Wei-Feng Li.   

Abstract

Industry-generated trans-fatty acids (TFA) are detrimental to risk of CHD, but ruminant-originated TFA have been reported as neutral or equivocal. Therefore, the total TFA amount should not be the only factor considered when measuring the effects of TFA. In the present study, we addressed whether a version of the TFA index that unifies the effects of different TFA isomers into one equation could be used to reflect CHD risk probability (RP). The present cross-sectional study involved 2713 individuals divided into four groups that represented different pathological severities and potential risks of CHD: acute coronary syndrome (ACS, n 581); chronic coronary artery disease (CCAD, n 631); high-risk population (HRP, n 659); healthy volunteers (HV, n 842). A 10-year CHD RP was calculated. Meanwhile, the equation of the TFA index was derived using five TFA isomers (trans-16 : 1n-7, trans-16 : 1n-9, trans-18 : 1n-7, trans-18 : 1n-9 and trans-18 : 2n-6n-9), which were detected in the whole blood, serum and erythrocyte membranes of each subject. The TFA index and the 10-year CHD RP were compared by linear models. It was shown that only in the erythrocyte membrane, the TFA isomers were significantly different between the groups. In the ACS group, industry-generated TFA (trans-16 : 1n-9, trans-18 : 1n-9 and trans-18 : 2n-6n-9) were the highest, whereas ruminant-originated TFA (trans-16 : 1n-7 and trans-18 : 1n-7), which manifested an inverse relationship with CHD, were the lowest, and vice versa in the HV group. The TFA index decreased progressively from 7·12 to 5·06, 3·11 and 1·92 in the ACS, CCAD, HRP and HV groups, respectively. The erythrocyte membrane TFA index was positively associated with the 10-year CHD RP (R 2 0·9981) and manifested a strong linear correlation, which might reflect the true pathological severity of CHD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433578     DOI: 10.1017/S0007114513000196

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  6 in total

1.  Whole milk compared with reduced-fat milk and childhood overweight: a systematic review and meta-analysis.

Authors:  Shelley M Vanderhout; Mary Aglipay; Nazi Torabi; Peter Jüni; Bruno R da Costa; Catherine S Birken; Deborah L O'Connor; Kevin E Thorpe; Jonathon L Maguire
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

2.  Trans-fatty acid levels in erythrocytes in Europe.

Authors:  Clemens von Schacky; Adrian Passow; Rosemarie Kiefl
Journal:  Eur J Nutr       Date:  2016-05-05       Impact factor: 5.614

3.  Quantitation of trans-fatty acids in human blood via isotope dilution-gas chromatography-negative chemical ionization-mass spectrometry.

Authors:  Heather C Kuiper; Na Wei; Samantha L McGunigale; Hubert W Vesper
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2018-01-06       Impact factor: 3.205

4.  Natural Rumen-Derived trans Fatty Acids Are Associated with Metabolic Markers of Cardiac Health.

Authors:  Marine S Da Silva; Pierre Julien; Louis Pérusse; Marie-Claude Vohl; Iwona Rudkowska
Journal:  Lipids       Date:  2015-07-26       Impact factor: 1.880

5.  A trans10-18:1 enriched fraction from beef fed a barley grain-based diet induces lipogenic gene expression and reduces viability of HepG2 cells.

Authors:  Payam Vahmani; William J Meadus; Maria L P da Silva; Alec D Mitchell; Cletos Mapiye; Pascale Duff; David C Rolland; Michael E R Dugan
Journal:  Biochem Biophys Rep       Date:  2016-05-27

6.  Effect of a dietary intervention including minimal and unprocessed foods, high in natural saturated fats, on the lipid profile of children, pooled evidence from randomized controlled trials and a cohort study.

Authors:  Rosanne Barbra Hendriksen; Ellen José van der Gaag
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.